IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v41y2018i11d10.1007_s40264-018-0686-7.html
   My bibliography  Save this article

Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample

Author

Listed:
  • Mai Duong

    (Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, CHU de Bordeaux
    INSERM U1219
    OXON Epidemiology)

  • Abdelilah Abouelfath

    (Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, CHU de Bordeaux)

  • Regis Lassalle

    (Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, CHU de Bordeaux)

  • Cécile Droz

    (Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, CHU de Bordeaux)

  • Patrick Blin

    (Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, CHU de Bordeaux)

  • Nicholas Moore

    (Bordeaux PharmacoEpi, INSERM CIC1401, University of Bordeaux, CHU de Bordeaux
    INSERM U1219)

Abstract

Introduction Non-steroidal anti-inflammatory drugs are associated with a dose and duration-dependent coronary risk. There is little information concerning analgesic-dose ibuprofen, among the most widely used drugs worldwide. Objective Our objective was to measure the risks of acute coronary syndrome (ACS) after dispensing of ibuprofen, versus paracetamol. Methods Propensity score 1:2-matched cohorts of ibuprofen or paracetamol treatment episodes (TEs) in Echantillon Généraliste de Bénéficiaires (EGB), the 1/97 sample of Système National des Données de Santé (SNDS), the French nationwide claims database, from 2009 to 2014, were compared. Outcomes were hospital admissions for ACS during the 3 months after the dispensing of ibuprofen or paracetamol. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated overall and stratified on low-dose aspirin dispensing. Results A total of 315,269 ibuprofen TEs in 168,400 persons were matched to 630,457 paracetamol TEs in 395,952 patients. Event rates were 50–100 times higher in low-dose aspirin users (27 vs 0.28 per 1000 patient years). Overall there was no difference in risk of ACS at 3 months (HR 0.94, 95% CI 0.74–1.20) despite a transient increase in the first 2 weeks in ibuprofen users (HR 1.70, 95% CI 1.11–2.59). In the stratified analysis, this short-term risk was only found in aspirin users (5% of population, HR 1.84, 95% CI 1.24–3.24), but not in non-aspirin users (HR 1.09, 95% CI 0.40–2.94). Conclusions There was no evidence for an increased risk of ACS in patients dispensed ibuprofen compared to paracetamol.

Suggested Citation

  • Mai Duong & Abdelilah Abouelfath & Regis Lassalle & Cécile Droz & Patrick Blin & Nicholas Moore, 2018. "Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample," Drug Safety, Springer, vol. 41(11), pages 1049-1058, November.
    • Handle: RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7
    DOI: 10.1007/s40264-018-0686-7
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-018-0686-7
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-018-0686-7?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Filippo Pigazzani & Isla Mackenzie & Thomas M. MacDonald, 2018. "Ibuprofen and Paracetamol: Acceptably Safe for All?," Drug Safety, Springer, vol. 41(11), pages 999-1001, November.
    2. Nicholas Moore & Stéphanie Duret & Adeline Grolleau & Régis Lassalle & Vanessa Barbet & Mai Duong & Nicolas Thurin & Cécile Droz-Perroteau & Sinem Ezgi Gulmez, 2019. "Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System," Drug Safety, Springer, vol. 42(4), pages 559-572, April.
    3. Clément Mathieu & Pierre Joly & Hélène Jacqmin-Gadda & Mathilde Wanneveich & Bernard Bégaud & Antoine Pariente, 2021. "Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study," Drug Safety, Springer, vol. 44(1), pages 53-62, January.
    4. Nicholas Moore, 2020. "Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update," Drug Safety, Springer, vol. 43(4), pages 301-318, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.